Lumida
/SMMT
⌘K
Summit Therapeutics Inc

Summit Therapeutics Inc

SMMT
$17.55USD+3.24%+0.55 today

MARKET CAP

14.0B

P/E (TTM)

FWD P/E

DAY RANGE

$17 – $18

52W RANGE

$12
$29

AI Summary

Stalk
StalkMedium

SMMT has triggered a clear momentum breakout and exhibits bullish medium-term structure supported by active continuation patterns. However, price is extended above rising EMAs with extreme overbought readings, warranting patience. A deferred buy on pullbacks into the rising 9/20 EMA zone aligns with speculative strategy discipline and manages risk against the longer-term downtrend.

  • Ibanesimab delivered statistically significant PFS in four Phase III trials.
  • $690.7M cash balance and zero debt fund PDUFA readiness.
  • Approval uncertain without statistically significant overall survival benefit.
Full analysis →
Insider Trades25 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jun 12, 2026BuySMMTRobert W DugganCo-Chief Executive Officer3,810,000$13.12$14.0B-39.96%+45.40%$50.0M+0.67%Buy Now
Jun 12, 2026BuySMMTMahkam ZanganehCo-Chief Executive Officer3,810,000$13.12$14.0B-39.96%+45.40%$50.0M+0.67%Buy Now
Jun 4, 2026BuySMMTManmeet Singh SoniCOO and CFO50,000$14.45$14.0B-39.96%+45.40%$722.3K+0.81%Buy Now
Jun 4, 2026BuySMMTMahkam ZanganehCo-Chief Executive Officer100,000$14.60$14.0B-39.96%+45.40%$1.5M+0.39%Buy Now
Jun 4, 2026BuySMMTRobert W DugganCo-Chief Executive Officer100,000$14.60$14.0B-39.96%+45.40%$1.5M+0.39%Buy Now
Oct 21, 2025BuySMMTBhaskar AnandChief Accounting Officer26,680$18.74$14.0B-39.96%+45.40%$500.0K+20.05%Buy Now
Oct 21, 2025BuySMMTManmeet Singh SoniCOO and CFO53,361$18.74$14.0B-39.96%+45.40%$1.0M+1.77%Buy Now
Oct 21, 2025BuySMMTMahkam ZanganehCo-Chief Executive Officer14,274,277$18.74$14.0B-39.96%+45.40%$267.5M+2.45%Buy Now
Oct 21, 2025BuySMMTRobert W DugganCo-Chief Executive Officer14,274,277$18.74$14.0B-39.96%+45.40%$267.5M+2.45%Buy Now
Sep 10, 2025BuySMMTRobert W DugganCo-Chief Executive Officer338,394$17.69$14.0B-39.96%+45.40%$6.0M+0.03%Buy Now
Sep 10, 2025BuySMMTMahkam ZanganehCo-Chief Executive Officer338,394$17.69$14.0B-39.96%+45.40%$6.0M+0.03%Buy Now
May 30, 2025BuySMMTRobert W DugganCo-Chief Executive Officer74,545$2.64$14.0B-39.96%+45.40%$196.8K+0.01%Buy Now
May 30, 2025BuySMMTMahkam ZanganehCo-Chief Executive Officer74,545$2.64$14.0B-39.96%+45.40%$196.8K+0.01%Buy Now
Apr 8, 2025BuySMMTRobert W DugganCo-Chief Executive Officer3,985,055$1.58$14.0B-39.96%+45.40%$6.3M+0.72%Buy Now
Apr 8, 2025BuySMMTMahkam ZanganehCo-Chief Executive Officer3,985,055$1.58$14.0B-39.96%+45.40%$6.3M+0.72%Buy Now
Oct 3, 2024BuySMMTMahkam ZanganehCo-Chief Executive Officer315,681$1.58$14.0B-39.96%+45.40%$498.8K+3.19%Buy Now
Sep 11, 2024BuySMMTBhaskar AnandChief Accounting Officer22,026$22.70$14.0B-39.96%+45.40%$500.0K+20.13%Buy Now
Sep 11, 2024BuySMMTManmeet Singh SoniCOO and CFO44,052$22.70$14.0B-39.96%+45.40%$1.0M+1.48%Buy Now
Sep 11, 2024BuySMMTMahkam ZanganehCo-Chief Executive Officer44,052$22.70$14.0B-39.96%+45.40%$1.0M+0.18%Buy Now
Sep 11, 2024BuySMMTRobert W DugganCo-Chief Executive Officer3,325,991$22.70$14.0B-39.96%+45.40%$75.5M+0.61%Buy Now
Mar 27, 2024BuySMMTMahkam ZanganehChief Executive Officer110,321$3.73$14.0B-39.96%+45.40%$411.1K+0.43%Buy Now
Mar 26, 2024BuySMMTAnkur DhingraChief Financial Officer100,000$3.75$14.0B-39.96%+45.40%$375.0K+39.22%Buy Now
Dec 13, 2023BuySMMTAnkur DhingraChief Financial Officer20,400$2.17$14.0B-39.96%+45.40%$44.3K+4.34%Buy Now
Dec 11, 2023BuySMMTMahkam ZanganehChief Executive Officer810,495$1.50$14.0B-39.96%+45.40%$1.2M+3.23%Buy Now
Oct 13, 2023BuySMMTManmeet Singh SoniChief Operating Officer2,976,190$1.68$14.0B-39.96%+45.40%$5.0M+21.26%Buy Now